Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer

Overview

cited authors

Weiss, Jared M.; Villaruz, Liza C.; O'Brien, Jonathon; Ivanova, Anastasia; Lee, Carrie; Olson, Juneko Grilley; Pollack, Gregory; Gorman, Richard; Socinski, Mark A.; Stinchombe, Thomas E.

authors

Socinski, Mark A., MD

Publication Date

March 1, 2016

webpage

Web of Science

published in

CLINICAL LUNG CANCER Journal

Research

keywords

Adenocarcinoma
Bevacizumab
Carboplatin
Light smoker
Never smoker
Pemetrexed

Additional Document Info

start page

end page

volume

issue

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.